Alcobra Ltd. (ADHD) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. DVN
5. CRGY
6. SPY
7. RMR
8. GOOG
9. ANGO
10. LULU

Go back to Alcobra Ltd. (ADHD) Tops Q1 EPS by 4c

Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update

May 16, 2016 8:01 AM EDT

Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time

TEL AVIV, Israel, May 16, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq: ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (Fragile X), today announced financial results for the three months ended March 31, 2016, and provided a corporate update.

First Quarter Ended March 31, 2016 Financial Results:

Total operating expenses in the first quarter 2016 were $5.2 million, in... More